CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 158 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,999,313 | +90.8% | 208,207 | +15.0% | 0.04% | +60.7% |
| Q1 2023 | $4,191,863 | -8.1% | 181,074 | +4.1% | 0.03% | -26.3% |
| Q4 2022 | $4,559,088 | +62.0% | 174,011 | +21.6% | 0.04% | +26.7% |
| Q3 2022 | $2,814,000 | +309.6% | 143,118 | +264.1% | 0.03% | +400.0% |
| Q2 2022 | $687,000 | -47.1% | 39,302 | -50.5% | 0.01% | -25.0% |
| Q1 2022 | $1,298,000 | +21.8% | 79,339 | +21.4% | 0.01% | +33.3% |
| Q4 2021 | $1,066,000 | +81.0% | 65,364 | +41.6% | 0.01% | +50.0% |
| Q3 2021 | $589,000 | +63.6% | 46,155 | +81.3% | 0.00% | +100.0% |
| Q2 2021 | $360,000 | – | 25,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |